Matches in Nanopublications for { ?s ?p "[Frequencies were in detail: acute myeloid leukemia (AML): 40 of 3,798, 1.1%; myelodysplastic syndromes (MDS): 6 of 3,375, 0.2%; myeloproliferative neoplasms (MPNs): 5 of 1,720, 0.3%; MDS/MPN: 0 of 210; and chronic myelomonocytic leukemia: 0 of 447.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP953877.RAuHgF0LmDum5BnsA6RJmIz0MMHYLVgt14t04bLJJJzhA130_assertion description "[Frequencies were in detail: acute myeloid leukemia (AML): 40 of 3,798, 1.1%; myelodysplastic syndromes (MDS): 6 of 3,375, 0.2%; myeloproliferative neoplasms (MPNs): 5 of 1,720, 0.3%; MDS/MPN: 0 of 210; and chronic myelomonocytic leukemia: 0 of 447.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953877.RAuHgF0LmDum5BnsA6RJmIz0MMHYLVgt14t04bLJJJzhA130_provenance.
- NP946141.RAXetWDsJWWb-NkffiUEVop63_MAYwwCGlq_lCOFbnQzU130_assertion description "[Frequencies were in detail: acute myeloid leukemia (AML): 40 of 3,798, 1.1%; myelodysplastic syndromes (MDS): 6 of 3,375, 0.2%; myeloproliferative neoplasms (MPNs): 5 of 1,720, 0.3%; MDS/MPN: 0 of 210; and chronic myelomonocytic leukemia: 0 of 447.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946141.RAXetWDsJWWb-NkffiUEVop63_MAYwwCGlq_lCOFbnQzU130_provenance.
- NP953869.RAIcHM1UaRKgHtC6BCRP9-2oR0MWndW4U_9qS_N3oVrFw130_assertion description "[Frequencies were in detail: acute myeloid leukemia (AML): 40 of 3,798, 1.1%; myelodysplastic syndromes (MDS): 6 of 3,375, 0.2%; myeloproliferative neoplasms (MPNs): 5 of 1,720, 0.3%; MDS/MPN: 0 of 210; and chronic myelomonocytic leukemia: 0 of 447.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953869.RAIcHM1UaRKgHtC6BCRP9-2oR0MWndW4U_9qS_N3oVrFw130_provenance.
- NP953884.RAII2e3xtSRei_l8YnEEi8YgPzTxKgdNEnYKLYbiwL-TM130_assertion description "[Frequencies were in detail: acute myeloid leukemia (AML): 40 of 3,798, 1.1%; myelodysplastic syndromes (MDS): 6 of 3,375, 0.2%; myeloproliferative neoplasms (MPNs): 5 of 1,720, 0.3%; MDS/MPN: 0 of 210; and chronic myelomonocytic leukemia: 0 of 447.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953884.RAII2e3xtSRei_l8YnEEi8YgPzTxKgdNEnYKLYbiwL-TM130_provenance.
- NP946142.RA9ZZlTBP6LHf5hy7UZXhmaxQREkMuBSS2XN-umSgyhMA130_assertion description "[Frequencies were in detail: acute myeloid leukemia (AML): 40 of 3,798, 1.1%; myelodysplastic syndromes (MDS): 6 of 3,375, 0.2%; myeloproliferative neoplasms (MPNs): 5 of 1,720, 0.3%; MDS/MPN: 0 of 210; and chronic myelomonocytic leukemia: 0 of 447.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946142.RA9ZZlTBP6LHf5hy7UZXhmaxQREkMuBSS2XN-umSgyhMA130_provenance.